pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-19a |
Genomic Coordinates | chr13: 91350891 - 91350972 |
Synonyms | MIRN19A, hsa-mir-19a, miR-19a, miRNA19A, MIR19A |
Description | Homo sapiens miR-19a stem-loop |
Comment | This sequence maps to chromosome 13 and is named miR-19a precursor-13 in reference . |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-19a-5p | ||||||||||||||||||||||||||||||
Sequence | 14| AGUUUUGCAUAGUUGCACUACA |35 | ||||||||||||||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||||||||||||||
Experiments | Cloned | ||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Biomarker Information |
|
---|
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | FAM13B | ||||||||||||||||||||
Synonyms | ARHGAP49, C5orf5, FAM13B1, KHCHP, N61 | ||||||||||||||||||||
Description | family with sequence similarity 13 member B | ||||||||||||||||||||
Transcript | NM_001101800 | ||||||||||||||||||||
Other Transcripts | NM_001101801 , NM_016603 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on FAM13B | |||||||||||||||||||||
3'UTR of FAM13B (miRNA target sites are highlighted) |
>FAM13B|NM_001101800|3'UTR 1 GATACGTTCCTTGAAAATTCATATCATAAAGTCAGTTGTATTCCTTGAAGCTATCATCGTGTGTACTTGGCTGGTACTTA 81 AATTCGTTTTGTCAGGCACTCAGAGAATCTCATTTTGTACTTGGTTGTGGTGCCACTAAACAAAACAAATGATGGGAGAG 161 TAAGTAGGCCCTCTCAAGGGAGCGTAAGTGATGTTCCATATTAACCACAGACTGTCCTCTCCACCTTTAGCAAACATATG 241 GTTTACTTCATTGTTTTGTACTACAGATACATCCTTTTAGCAAAAGACTGGAATTTTATCCTTTCAACTTCAAGAACTTT 321 GGAAATGCAAGCTTTTTGTTATTACCAACTTTTTGTTTCTCATTACTGAAGAAAATTGGAGGAAAATCTTCATACTGAAT 401 TCTTCTGTTGCCTTTTTCTTACAGAATGACTGAAAATTTGAAAGAAAAGCCTATAAAAGTGCACATACGCAACTGTGTTC 481 TCTGTTTTCCTAGAAAACCAAAATCAAACTGAGATTTCAAGTCGTACTATGGAACACCTTTCTGTTTAATTCCCAAAGTG 561 ACATCTTCTCACAGGTAGTATGTTAGTAAAATTTTGCAATTCGCTGGTCACACAGCTCCCGGATGAAGATAACAGTTGGT 641 AGACCAAAAGGTGACCTCGCTTAGTATATTGAAAACACACACCACACATCACACACAGAACTGAATCATACCACATGCTG 721 CCTATGGGACTTCAGTTACTGTTTCCTGAGTTACTGTTTATCCGCTGGCAATGGTGTGATTTGTCTGGATCAGATCCGCG 801 CTATTCCCCAACCCACCTCCAGATAATGTGAGAAAATAGCCATGTCAGTATGTAGGAACTCTGATGGTGCTCAGATTTGT 881 GTGTTCAATCAATGGGCTTAAATCAGCAAAATATTATGCCTAAAGTAAATCTGTTCTTAACAAGGGCTCTACCACTGCAT 961 TTTCACATGTACCTTCAGGGGGTTATCTTTTTTTTTTTCCCCTCCTATTTTAATCAGCAAAATCCATACCAAAACAACGA 1041 CAACAACGCCCTCTTAAGGGACCACCCTTTGGTCAATCATAACATGCTGTTTAAAGCAGCTGTTTACAGGATGTGTAGTG 1121 GTATGCCCCTTGTCATATACTCTTAGCATATCTTTTTTTCCTTTGGCTTTGCATGGCTTTTCTTCAGGTACTGTCTCGGT 1201 ATCATTCTGCTAATCATTGTTACAGAATGGTGACTTCATTTGTGCTAACAGTACAACAGCAGATTTGGGTCAGGCTTAAT 1281 CTAAGTGTTAACTTTTTTTTCTGGTGCTTTTTTGGATTGATGACTGTCTCACTTTGACTATACCCATGTTTTGCATGCAA 1361 TGACTCATGCATGGTTTTCTTAACTAGCTAATATTAACAATTTATTCCATATAAAAATGGAATTTTGCAACATCCTTTAA 1441 TAAGGTGAGGGAAGCATGAACCTCAGACTTCTGGCACTATTACATAGTAAGCACATGAAGTAGTTTGATAATAAATAGCA 1521 GTTCTAGTACTTCACATTTCACCCGTGTGTGCAATGCCTTTTTCTGGGGGGTGGGGGGTGAGGGAAAACCTGGTAGTGAA 1601 TGTGTAGTTGGGGAATAAAGAAAAGCACTAAATCCTGCCCTTTTTGTGTGGTTTCCTTTTGATACAACTAGGTTATTCAT 1681 AATGTATACCTAGAAAAGTGAAATTGAAAATACCAAAAGATGTATCATTTTTATTTGAATCCATCATGCAGTGTACATTT 1761 CAGATAATTTCCTTCAGTCTCCAGATAGGAGTGTATCCAAACATCTAATTTTATGTGCACTGTGTATCTTATATGAATGT 1841 TTTATTTTATATACCACATGCAAAAATGTCCATATGCACTATTTAAATGTTTTAAATAATATATTCCTTCTTTATAATGC 1921 TAAATCTATATGAGTACCATATTTTTATAAGTCAGTGGTCTGACTGGTTTCATTTTAGAATTAACAGCTGCTTCAATATG 2001 TTATTCAATGTTAATGTTTGGCTGTGAGTAGAATATGTAAAAGTGGCATGGCAGCACTTATGCTCTGTGACAGTATTGTG 2081 TGTCATAGTTGAGCAGTAGCTGGTAGAATTAGGCAGTTGGTGATAGTTTTACTTTGGTACAAATAAAAACTGTATATCTA 2161 TATACAAATAATATATAGATATATATGTCCACCAGTATAATGGCATTGCTGTGTCTGGCACTTCATTGTACAGACTTTTA 2241 TAATAAAAGAACTTGAAAGTTCTAAGTCATTGTAAATGTATGTTTGTTTTTCCACTGGGCTTAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293S |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1084065. RNA binding protein: AGO2. Condition:CLIP_emetine_AbnovaAb
... - Karginov FV; Hannon GJ, 2013, Genes & development. |
Article |
- Karginov FV; Hannon GJ - Genes & development, 2013
When adapting to environmental stress, cells attenuate and reprogram their translational output. In part, these altered translation profiles are established through changes in the interactions between RNA-binding proteins and mRNAs. The Argonaute 2 (Ago2)/microRNA (miRNA) machinery has been shown to participate in stress-induced translational up-regulation of a particular mRNA, CAT-1; however, a detailed, transcriptome-wide understanding of the involvement of Ago2 in the process has been lacking. Here, we profiled the overall changes in Ago2-mRNA interactions upon arsenite stress by cross-linking immunoprecipitation (CLIP) followed by high-throughput sequencing (CLIP-seq). Ago2 displayed a significant remodeling of its transcript occupancy, with the majority of 3' untranslated region (UTR) and coding sequence (CDS) sites exhibiting stronger interaction. Interestingly, target sites that were destined for release from Ago2 upon stress were depleted in miRNA complementarity signatures, suggesting an alternative mode of interaction. To compare the changes in Ago2-binding patterns across transcripts with changes in their translational states, we measured mRNA profiles on ribosome/polysome gradients by RNA sequencing (RNA-seq). Increased Ago2 occupancy correlated with stronger repression of translation for those mRNAs, as evidenced by a shift toward lighter gradient fractions upon stress, while release of Ago2 was associated with the limited number of transcripts that remained translated. Taken together, these data point to a role for Ago2 and the mammalian miRNAs in mediating the translational component of the stress response.
LinkOut: [PMID: 23824327]
|
CLIP-seq Support 1 for dataset GSM1084065 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | HEK293S / CLIP_emetine_AbnovaAb |
Location of target site | ENST00000033079.3 | 3UTR | AACAAAUGAUGGGAGAGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23824327 / GSE44404 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
92 hsa-miR-19a-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT038980 | WDR96 | cilia and flagella associated protein 43 | 1 | 1 | ||||||||
MIRT063864 | RASSF8 | Ras association domain family member 8 | 2 | 6 | ||||||||
MIRT077656 | IGF2BP1 | insulin like growth factor 2 mRNA binding protein 1 | 2 | 2 | ||||||||
MIRT078461 | MAP3K3 | mitogen-activated protein kinase kinase kinase 3 | 2 | 2 | ||||||||
MIRT095248 | FAM13B | family with sequence similarity 13 member B | 2 | 2 | ||||||||
MIRT109490 | KLHL15 | kelch like family member 15 | 2 | 6 | ||||||||
MIRT155378 | CCNT2 | cyclin T2 | 2 | 2 | ||||||||
MIRT163208 | EDEM1 | ER degradation enhancing alpha-mannosidase like protein 1 | 2 | 2 | ||||||||
MIRT188326 | ARID1A | AT-rich interaction domain 1A | 2 | 2 | ||||||||
MIRT204723 | BZW1 | basic leucine zipper and W2 domains 1 | 2 | 4 | ||||||||
MIRT236399 | HMGXB4 | HMG-box containing 4 | 2 | 2 | ||||||||
MIRT237114 | P2RY1 | purinergic receptor P2Y1 | 2 | 5 | ||||||||
MIRT286942 | SOCS7 | suppressor of cytokine signaling 7 | 2 | 2 | ||||||||
MIRT442523 | MOB3B | MOB kinase activator 3B | 2 | 2 | ||||||||
MIRT473428 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT476783 | FOS | Fos proto-oncogene, AP-1 transcription factor subunit | 2 | 2 | ||||||||
MIRT476942 | FAM83G | family with sequence similarity 83 member G | 2 | 2 | ||||||||
MIRT480184 | CALM2 | calmodulin 2 | 2 | 6 | ||||||||
MIRT489620 | ZNF384 | zinc finger protein 384 | 2 | 2 | ||||||||
MIRT492246 | SLC39A9 | solute carrier family 39 member 9 | 2 | 2 | ||||||||
MIRT492422 | RGL2 | ral guanine nucleotide dissociation stimulator like 2 | 2 | 2 | ||||||||
MIRT494860 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT497001 | SNAP25 | synaptosome associated protein 25 | 2 | 2 | ||||||||
MIRT501973 | MAPK6 | mitogen-activated protein kinase 6 | 2 | 2 | ||||||||
MIRT504917 | CD38 | CD38 molecule | 2 | 4 | ||||||||
MIRT507019 | HMGA2 | high mobility group AT-hook 2 | 2 | 6 | ||||||||
MIRT510820 | SBNO1 | strawberry notch homolog 1 | 2 | 4 | ||||||||
MIRT514166 | PGPEP1 | pyroglutamyl-peptidase I | 2 | 2 | ||||||||
MIRT514328 | PSMG2 | proteasome assembly chaperone 2 | 2 | 4 | ||||||||
MIRT514429 | SLC38A7 | solute carrier family 38 member 7 | 2 | 2 | ||||||||
MIRT514537 | ESR2 | estrogen receptor 2 | 2 | 2 | ||||||||
MIRT516117 | SRPX2 | sushi repeat containing protein, X-linked 2 | 2 | 4 | ||||||||
MIRT517759 | ZNF366 | zinc finger protein 366 | 2 | 4 | ||||||||
MIRT518495 | FAM161B | family with sequence similarity 161 member B | 2 | 4 | ||||||||
MIRT518512 | CASP10 | caspase 10 | 2 | 2 | ||||||||
MIRT518561 | GDPD1 | glycerophosphodiester phosphodiesterase domain containing 1 | 2 | 2 | ||||||||
MIRT518641 | NOM1 | nucleolar protein with MIF4G domain 1 | 2 | 2 | ||||||||
MIRT518729 | ABCG8 | ATP binding cassette subfamily G member 8 | 2 | 2 | ||||||||
MIRT523565 | GGCX | gamma-glutamyl carboxylase | 2 | 4 | ||||||||
MIRT526523 | YIPF6 | Yip1 domain family member 6 | 2 | 2 | ||||||||
MIRT530254 | ZNF620 | zinc finger protein 620 | 2 | 2 | ||||||||
MIRT531658 | ZFP14 | ZFP14 zinc finger protein | 2 | 2 | ||||||||
MIRT532699 | TCN2 | transcobalamin 2 | 2 | 4 | ||||||||
MIRT534019 | STXBP4 | syntaxin binding protein 4 | 2 | 2 | ||||||||
MIRT535748 | MYO10 | myosin X | 2 | 4 | ||||||||
MIRT544509 | GTF2E2 | general transcription factor IIE subunit 2 | 2 | 2 | ||||||||
MIRT546758 | RLIM | ring finger protein, LIM domain interacting | 2 | 2 | ||||||||
MIRT547929 | HNRNPR | heterogeneous nuclear ribonucleoprotein R | 2 | 2 | ||||||||
MIRT550130 | ZNF138 | zinc finger protein 138 | 2 | 2 | ||||||||
MIRT551763 | MED21 | mediator complex subunit 21 | 2 | 2 | ||||||||
MIRT557727 | FYCO1 | FYVE and coiled-coil domain containing 1 | 2 | 2 | ||||||||
MIRT558924 | CBX1 | chromobox 1 | 2 | 2 | ||||||||
MIRT562466 | CORO1C | coronin 1C | 2 | 2 | ||||||||
MIRT562759 | ZNF846 | zinc finger protein 846 | 2 | 2 | ||||||||
MIRT563061 | ZNF28 | zinc finger protein 28 | 2 | 2 | ||||||||
MIRT563336 | RPLP0 | ribosomal protein lateral stalk subunit P0 | 2 | 2 | ||||||||
MIRT569170 | DMD | dystrophin | 2 | 2 | ||||||||
MIRT573256 | TNFAIP6 | TNF alpha induced protein 6 | 2 | 2 | ||||||||
MIRT575057 | P2ry1 | purinergic receptor P2Y, G-protein coupled 1 | 2 | 4 | ||||||||
MIRT575360 | Zxda | zinc finger, X-linked, duplicated A | 2 | 2 | ||||||||
MIRT613233 | CCDC39 | coiled-coil domain containing 39 | 2 | 2 | ||||||||
MIRT613347 | ADRBK2 | G protein-coupled receptor kinase 3 | 2 | 6 | ||||||||
MIRT613952 | TMEM59 | transmembrane protein 59 | 2 | 2 | ||||||||
MIRT615488 | EDN1 | endothelin 1 | 2 | 2 | ||||||||
MIRT618710 | ESD | esterase D | 2 | 2 | ||||||||
MIRT630609 | ARHGAP1 | Rho GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT630619 | CXCR6 | C-X-C motif chemokine receptor 6 | 2 | 2 | ||||||||
MIRT630631 | IMPAD1 | inositol monophosphatase domain containing 1 | 2 | 2 | ||||||||
MIRT630674 | KLF7 | Kruppel like factor 7 | 2 | 2 | ||||||||
MIRT630746 | COG6 | component of oligomeric golgi complex 6 | 2 | 2 | ||||||||
MIRT636853 | ZSCAN2 | zinc finger and SCAN domain containing 2 | 2 | 2 | ||||||||
MIRT638642 | GPATCH8 | G-patch domain containing 8 | 2 | 2 | ||||||||
MIRT639106 | MMAB | methylmalonic aciduria (cobalamin deficiency) cblB type | 2 | 2 | ||||||||
MIRT639422 | PKP1 | plakophilin 1 | 2 | 2 | ||||||||
MIRT640187 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT641757 | SF3A1 | splicing factor 3a subunit 1 | 2 | 2 | ||||||||
MIRT666577 | RHOBTB3 | Rho related BTB domain containing 3 | 2 | 2 | ||||||||
MIRT672166 | FANCF | Fanconi anemia complementation group F | 2 | 2 | ||||||||
MIRT688345 | ETS1 | ETS proto-oncogene 1, transcription factor | 2 | 2 | ||||||||
MIRT690120 | ZFAND1 | zinc finger AN1-type containing 1 | 2 | 2 | ||||||||
MIRT696939 | CERK | ceramide kinase | 2 | 2 | ||||||||
MIRT701361 | NR4A3 | nuclear receptor subfamily 4 group A member 3 | 2 | 2 | ||||||||
MIRT703288 | GID4 | GID complex subunit 4 homolog | 2 | 2 | ||||||||
MIRT709146 | ZNF799 | zinc finger protein 799 | 2 | 2 | ||||||||
MIRT710848 | FAM210A | family with sequence similarity 210 member A | 2 | 2 | ||||||||
MIRT712621 | GTF2H5 | general transcription factor IIH subunit 5 | 2 | 2 | ||||||||
MIRT714591 | CMBL | carboxymethylenebutenolidase homolog | 2 | 2 | ||||||||
MIRT716909 | CACNB2 | calcium voltage-gated channel auxiliary subunit beta 2 | 2 | 2 | ||||||||
MIRT721165 | FAM200B | family with sequence similarity 200 member B | 2 | 2 | ||||||||
MIRT722404 | BCAS2 | BCAS2, pre-mRNA processing factor | 2 | 2 | ||||||||
MIRT722517 | DSTYK | dual serine/threonine and tyrosine protein kinase | 2 | 2 | ||||||||
MIRT724599 | AP3B1 | adaptor related protein complex 3 beta 1 subunit | 2 | 2 |
miRNA-Drug Associations | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|